Transaction in Own Shares

PureTech Health PLC
07 November 2023
 

7 November 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

6 November 2023



Number of ordinary shares purchased:

40,474



Highest price paid per share:

162.80p



Lowest price paid per share:

161.40p



Volume weighted average price paid per share:

162.31p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,125,715 ordinary shares in treasury and has 273,342,444 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,342,444 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

06/11/2023

11:51:16

227

162.8

AQXE

00377261558TRLO0.1.1

06/11/2023

11:51:16

291

162.8

BATE

00377261560TRLO0.1.1

06/11/2023

11:51:16

216

162.8

AQXE

00377261559TRLO0.1.1

06/11/2023

11:51:16

291

162.8

BATE

00377261561TRLO0.1.1

06/11/2023

11:51:16

291

162.8

CHIX

00377261562TRLO0.1.1

06/11/2023

11:51:16

11

162.8

AQXE

00377261564TRLO0.1.1

06/11/2023

11:51:16

291

162.8

XLON

00377261563TRLO0.1.1

06/11/2023

12:01:22

291

162.6

XLON

00377262358TRLO0.1.1

06/11/2023

12:01:22

291

162.6

XLON

00377262359TRLO0.1.1

06/11/2023

12:01:22

89

162.6

TRQX

00377262360TRLO0.1.1

06/11/2023

12:17:16

132

162.2

XLON

00377263292TRLO0.1.1

06/11/2023

12:17:16

291

162.2

CHIX

00377263293TRLO0.1.1

06/11/2023

12:17:16

16

162.2

CHIX

00377263295TRLO0.1.1

06/11/2023

12:17:16

66

162.2

CHIX

00377263294TRLO0.1.1

06/11/2023

12:17:16

11

162.2

XLON

00377263296TRLO0.1.1

06/11/2023

14:10:17

239

162.8

CHIX

00377279946TRLO0.1.1

06/11/2023

14:10:17

291

162.8

BATE

00377279948TRLO0.1.1

06/11/2023

14:10:17

156

162.8

CHIX

00377279947TRLO0.1.1

06/11/2023

14:10:17

312

162.8

XLON

00377279949TRLO0.1.1

06/11/2023

14:10:17

439

162.8

XLON

00377279950TRLO0.1.1

06/11/2023

14:10:17

291

162.8

XLON

00377279951TRLO0.1.1

06/11/2023

14:10:17

89

162.8

TRQX

00377279952TRLO0.1.1

06/11/2023

14:10:22

1

162.8

AQXE

00377279964TRLO0.1.1

06/11/2023

14:10:27

1

162.8

AQXE

00377279973TRLO0.1.1

06/11/2023

14:10:32

1

162.8

AQXE

00377280021TRLO0.1.1

06/11/2023

14:10:37

15

162.8

AQXE

00377280030TRLO0.1.1

06/11/2023

14:10:42

61

162.8

AQXE

00377280048TRLO0.1.1

06/11/2023

14:10:47

1

162.8

AQXE

00377280055TRLO0.1.1

06/11/2023

14:10:52

1

162.8

AQXE

00377280063TRLO0.1.1

06/11/2023

14:10:58

121

162.8

AQXE

00377280074TRLO0.1.1

06/11/2023

14:11:03

21

162.8

AQXE

00377280081TRLO0.1.1

06/11/2023

14:11:08

1

162.8

AQXE

00377280095TRLO0.1.1

06/11/2023

14:11:12

1

162.8

AQXE

00377280127TRLO0.1.1

06/11/2023

14:11:16

1

162.8

AQXE

00377280137TRLO0.1.1

06/11/2023

14:11:18

1

162.8

AQXE

00377280149TRLO0.1.1

06/11/2023

14:32:43

1143

162.8

XLON

00377284402TRLO0.1.1

06/11/2023

14:32:43

291

162.8

XLON

00377284403TRLO0.1.1

06/11/2023

14:33:26

357

162.8

CHIX

00377284646TRLO0.1.1

06/11/2023

14:33:26

4

162.6

XLON

00377284650TRLO0.1.1

06/11/2023

14:33:26

4

162.6

XLON

00377284651TRLO0.1.1

06/11/2023

14:36:45

251

162.6

XLON

00377285449TRLO0.1.1

06/11/2023

14:36:45

133

162.6

XLON

00377285450TRLO0.1.1

06/11/2023

14:36:45

32

162.6

XLON

00377285451TRLO0.1.1

06/11/2023

14:36:45

251

162.6

XLON

00377285452TRLO0.1.1

06/11/2023

14:36:45

153

162.6

XLON

00377285454TRLO0.1.1

06/11/2023

14:36:45

158

162.6

XLON

00377285453TRLO0.1.1

06/11/2023

14:36:45

40

162.6

XLON

00377285455TRLO0.1.1

06/11/2023

14:36:45

138

162.6

XLON

00377285456TRLO0.1.1

06/11/2023

14:43:40

131

162.8

XLON

00377287194TRLO0.1.1

06/11/2023

14:43:40

742

162.8

XLON

00377287195TRLO0.1.1

06/11/2023

14:54:30

330

162.8

CHIX

00377290019TRLO0.1.1

06/11/2023

14:54:30

28

162.4

BATE

00377290022TRLO0.1.1

06/11/2023

14:54:30

163

162.4

BATE

00377290021TRLO0.1.1

06/11/2023

14:54:30

128

162.4

BATE

00377290020TRLO0.1.1

06/11/2023

14:54:30

1

162.4

BATE

00377290023TRLO0.1.1

06/11/2023

14:54:30

75

162.4

BATE

00377290024TRLO0.1.1

06/11/2023

14:54:30

582

162.4

XLON

00377290025TRLO0.1.1

06/11/2023

14:54:30

35

162.4

XLON

00377290027TRLO0.1.1

06/11/2023

14:54:30

122

162.4

XLON

00377290028TRLO0.1.1

06/11/2023

14:54:30

169

162.4

XLON

00377290026TRLO0.1.1

06/11/2023

14:54:30

151

162.4

XLON

00377290030TRLO0.1.1

06/11/2023

14:54:30

291

162.4

XLON

00377290029TRLO0.1.1

06/11/2023

14:54:30

256

162.4

XLON

00377290032TRLO0.1.1

06/11/2023

14:54:30

140

162.4

XLON

00377290031TRLO0.1.1

06/11/2023

14:54:30

2

162.4

AQXE

00377290033TRLO0.1.1

06/11/2023

14:54:30

89

162

TRQX

00377290034TRLO0.1.1

06/11/2023

14:54:30

225

162.4

AQXE

00377290035TRLO0.1.1

06/11/2023

14:56:04

41

161.4

XLON

00377290532TRLO0.1.1

06/11/2023

14:59:19

250

161.4

XLON

00377291321TRLO0.1.1

06/11/2023

15:02:26

254

161.4

XLON

00377292427TRLO0.1.1

06/11/2023

15:04:56

37

161.4

XLON

00377293340TRLO0.1.1

06/11/2023

15:04:56

291

161.4

XLON

00377293341TRLO0.1.1

06/11/2023

15:04:56

150

161.4

XLON

00377293342TRLO0.1.1

06/11/2023

15:07:50

141

161.4

XLON

00377294349TRLO0.1.1

06/11/2023

15:07:50

291

161.4

XLON

00377294350TRLO0.1.1

06/11/2023

15:07:50

114

161.4

XLON

00377294351TRLO0.1.1

06/11/2023

15:11:01

63

161.4

XLON

00377295401TRLO0.1.1

06/11/2023

15:11:01

452

161.4

XLON

00377295402TRLO0.1.1

06/11/2023

15:14:18

485

161.4

XLON

00377296639TRLO0.1.1

06/11/2023

15:15:26

291

162.2

CHIX

00377297054TRLO0.1.1

06/11/2023

15:18:49

20

161.4

CHIX

00377298137TRLO0.1.1

06/11/2023

15:20:45

89

161.4

CHIX

00377298724TRLO0.1.1

06/11/2023

15:21:33

466

161.4

CHIX

00377298933TRLO0.1.1

06/11/2023

15:22:56

1

162.2

BATE

00377299268TRLO0.1.1

06/11/2023

15:22:56

477

162.2

BATE

00377299267TRLO0.1.1

06/11/2023

15:22:58

89

162.2

TRQX

00377299272TRLO0.1.1

06/11/2023

15:32:06

1949

162.4

XLON

00377302148TRLO0.1.1

06/11/2023

15:32:06

227

162.4

AQXE

00377302149TRLO0.1.1

06/11/2023

15:32:06

3048

162.4

XLON

00377302150TRLO0.1.1

06/11/2023

15:32:06

239

162.2

CHIX

00377302152TRLO0.1.1

06/11/2023

15:32:06

20

162.2

CHIX

00377302154TRLO0.1.1

06/11/2023

15:32:06

52

162.2

CHIX

00377302153TRLO0.1.1

06/11/2023

15:32:06

65

162.2

CHIX

00377302155TRLO0.1.1

06/11/2023

15:39:51

63

161.6

BATE

00377304618TRLO0.1.1

06/11/2023

15:39:51

98

161.6

BATE

00377304617TRLO0.1.1

06/11/2023

15:39:51

291

161.6

BATE

00377304616TRLO0.1.1

06/11/2023

15:39:51

35

161.6

BATE

00377304619TRLO0.1.1

06/11/2023

15:42:42

95

161.6

BATE

00377305422TRLO0.1.1

06/11/2023

15:59:18

291

162.8

XLON

00377310997TRLO0.1.1

06/11/2023

15:59:18

97

162.6

CHIX

00377310999TRLO0.1.1

06/11/2023

15:59:18

385

162.6

CHIX

00377310998TRLO0.1.1

06/11/2023

15:59:18

22

162.6

CHIX

00377311000TRLO0.1.1

06/11/2023

15:59:18

2328

162.6

XLON

00377311001TRLO0.1.1

06/11/2023

16:04:28

140

162

AQXE

00377312979TRLO0.1.1

06/11/2023

16:04:28

291

162

CHIX

00377312980TRLO0.1.1

06/11/2023

16:06:45

14

162

AQXE

00377313830TRLO0.1.1

06/11/2023

16:06:45

87

162

AQXE

00377313831TRLO0.1.1

06/11/2023

16:06:45

60

162

AQXE

00377313832TRLO0.1.1

06/11/2023

16:06:45

128

162

BATE

00377313833TRLO0.1.1

06/11/2023

16:06:45

167

162

AQXE

00377313834TRLO0.1.1

06/11/2023

16:09:23

371

162.4

XLON

00377314708TRLO0.1.1

06/11/2023

16:09:23

500

162.4

XLON

00377314709TRLO0.1.1

06/11/2023

16:11:38

293

162.4

XLON

00377315466TRLO0.1.1

06/11/2023

16:11:38

242

162.4

XLON

00377315467TRLO0.1.1

06/11/2023

16:12:09

1504

162.4

XLON

00377315656TRLO0.1.1

06/11/2023

16:12:09

871

162.4

XLON

00377315657TRLO0.1.1

06/11/2023

16:12:09

40

162.4

XLON

00377315658TRLO0.1.1

06/11/2023

16:12:09

160

162.4

XLON

00377315659TRLO0.1.1

06/11/2023

16:12:09

673

162.4

XLON

00377315660TRLO0.1.1

06/11/2023

16:14:21

163

162

BATE

00377316536TRLO0.1.1

06/11/2023

16:14:21

181

162

BATE

00377316537TRLO0.1.1

06/11/2023

16:14:21

110

162

BATE

00377316538TRLO0.1.1

06/11/2023

16:14:21

84

162

BATE

00377316539TRLO0.1.1

06/11/2023

16:14:53

213

162

AQXE

00377316729TRLO0.1.1

06/11/2023

16:14:53

291

162

CHIX

00377316730TRLO0.1.1

06/11/2023

16:14:53

291

162

CHIX

00377316731TRLO0.1.1

06/11/2023

16:14:53

207

162

BATE

00377316733TRLO0.1.1

06/11/2023

16:14:53

211

162

CHIX

00377316734TRLO0.1.1

06/11/2023

16:14:53

130

162

AQXE

00377316732TRLO0.1.1

06/11/2023

16:14:53

279

161.8

CHIX

00377316735TRLO0.1.1

06/11/2023

16:14:53

89

162

TRQX

00377316737TRLO0.1.1

06/11/2023

16:14:53

3492

162

XLON

00377316736TRLO0.1.1

06/11/2023

16:14:53

1295

161.8

XLON

00377316738TRLO0.1.1

06/11/2023

16:14:53

45

162

TRQX

00377316739TRLO0.1.1

06/11/2023

16:14:53

44

162

TRQX

00377316740TRLO0.1.1

06/11/2023

16:14:55

291

162

BATE

00377316751TRLO0.1.1

06/11/2023

16:17:34

178

161.8

BATE

00377317603TRLO0.1.1

06/11/2023

16:17:34

113

161.8

BATE

00377317604TRLO0.1.1

06/11/2023

16:26:38

383

162.4

CHIX

00377321230TRLO0.1.1

06/11/2023

16:26:38

117

162.4

CHIX

00377321231TRLO0.1.1

06/11/2023

16:26:38

500

162.4

XLON

00377321232TRLO0.1.1

06/11/2023

16:29:15

96

162.8

BATE

00377322216TRLO0.1.1

06/11/2023

16:29:15

873

162.8

BATE

00377322217TRLO0.1.1

06/11/2023

16:29:49

1

162.8

BATE

00377322655TRLO0.1.1

06/11/2023

16:29:58

194

162.8

BATE

00377322810TRLO0.1.1

06/11/2023

16:29:58

291

162.8

BATE

00377322811TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings